+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer

Anticancer Research 38(5): 2841-2848

mutS homolog 2 (MSH2) deficiency may be involved in the development of microsatellite instability found in certain sporadic colorectal tumors. In addition to mutations or loss of heterozygosity resulting in complete loss of MSH2 function, polymorphisms affecting MSH2 expression have been also identified. Therefore, the aim of this study was to examine MSH2 status in sporadic colon cancer. MSH2 status was examined at the DNA, RNA and protein levels through loss of heterozygosity (LOH) analysis, quantitative real-time PCR and immunohistochemistry. MSH2 IVS10+12A>G polymorphism was examined by real-time single nucleotide polymorphism genotyping. MSH2 LOH was more frequent in tumors larger than 5 cm (p=0.032), mRNA expression was also significantly lower and the same expression pattern was present in the corresponding normal mucosa of the same patient (p=0.013 and p=0.008, respectively). No association was found between IVS10+12A>G polymorphism and susceptibility to sporadic colon cancer. Altered MSH2 expression detected in sporadic colon tumors pointing to its role in colorectal tumorigenesis without a hereditary component.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046802569

Download citation: RISBibTeXText

PMID: 29715107

Related references

NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54(8): 1129-1135, 2005

Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. Journal of Molecular Diagnostics 7(5): 623-630, 2005

Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer. Journal of Molecular Medicine 77(3): 316-321, 1999

DPC4 tumor suppressor gene in human sporadic colon cancer; loss of heterozygosity. European Journal of Human Genetics 9(Suppl. 1): P0123, 2001

Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer. Journal of Molecular Medicine 79(2-3): 128-132, 2001

Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. Oncology Letters 6(5): 1413-1420, 2013

APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Experimental and Molecular Pathology 77(3): 193-200, 2004

Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation. Journal of Clinical Pathology 72(6): 443-447, 2019

Loss of MSH2 heterozygosity in sebaceous tumors from patients with MSH2 germline mutations. Archives of Dermatological Research 293(1-2): 94, 2001

Microsatellite instability (MSI) and MLH1 and MSH2 protein expression analysis in postmenopausal women with sporadic endometrial cancer. Journal of Experimental and Clinical Cancer Research 26(3): 369-374, 2007

Interleukin-6-174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer. Dna and Cell Biology 29(4): 177-182, 2010

Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Research 59(23): 5995-5998, 1999

Loss of heterozygosity analysis to define putative region involved in tumor differentiation and metastases in sporadic colorectal cancer patients. Zhonghua Wai Ke Za Zhi 40(10): 776-779, 2002

Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients. Chinese Journal of Cancer 29(8): 761-767, 2010

Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut 53(3): 371-375, 2004